June 11, 2021News, Past Events

Facebook Live: What Does Aducanumab Mean for Alzheimer’s?

Dr. Dale Bredesen and Julie Gregory discussed the FDA’s approval Biogen’s drug Aduhelm and the ramifications for those seeking treatment for Alzheimer’s. Read More »

June 9, 2021News

Aducanumab vs. the ReCODE Protocol

The recently FDA approved Aduhelm did not improve cognition but mildly slowed down disease progression with dangerous side effects compared to the ReCODE Protocol, which in a recent trial demonstrated that 84% of the participants improved cognition with health optimization as the only side effect. Read More »

June 9, 2021Interviews, News

FDA Approves New Alzheimer’s Drug Despite Little Evidence it Works

Dr. Bredesen speaks with CBN News’ reporter, Lorie Johnson, about the recent FDA approval of the Alzheimer’s drug Aduhelm. Read More »

June 7, 2021From Ram Rao, News

The Ill Effects of Prolonged Sitting

Dr. Ram Rao discusses how prolonged sitting has serious detrimental effects on our bodies and health. Read More »

June 7, 2021From Julie Gregory, Insider Strategies, News

Jump-Start Spring Detox

Julie Gregory discusses the importance of stimulating the lymphatic system to upregulate our body’s ability to detoxify. Read More »

June 7, 2021From Dr. Bredesen, News

Finally — Clinical Trial Demonstrates Reversal of Cognitive Decline

Dr. Bredesen writes about his successful clinical trial using precision medicine that addresses the multiple causes of Alzheimer’s. Read More »

May 29, 2021News

Facebook Live: Clinical Trial Discussion

Dr. Dale Bredesen and Julie Gregory, were joined by Dr. Kat Toups to discuss their recently published Alzheimer’s clinical trial. Read More »

May 26, 2021Interviews, News

Precision Medicine Study Points to Promising New Approach in Alzheimer’s

BioSpace’s Heather McKenzie spoke with Dr. Bredesen about the recently published results from the study “Precision Medicine Approach to Alzheimer’s Disease: Successful Proof-of-Concept Trial.” Read More »